Modulators of toll-like receptor 7

US9611268B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9611268-B2
Application numberUS-201514626738-A
CountryUS
Kind codeB2
Filing dateFeb 19, 2015
Priority dateJun 29, 2007
Publication dateApr 4, 2017
Grant dateApr 4, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application includes a compound of Formula I or II: or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods that include the administration of such compounds with at least one additional active agent.

First claim

Opening claim text (preview).

What is claimed: 1. A compound represented by Formula IIa: or a pharmaceutically acceptable salt thereof, wherein: R 1 is —NR 4 R 5 ; R 2 is alkyl, alkenyl, carbocyclyl, carbocyclylalkyl, arylalkyl, or substituted arylalkyl; -L 3 -R 3 is —O-alkyl or —O-alkylene-O-alkyl; R 4 and R 5 are each independently H, or carbocyclylalkyl; or R 4 and R 5 , taken together with the nitrogen to which they are both attached, form an unsubstituted heterocycle, wherein the heterocycle is a 4- to 6-membered monocyclic fully saturated ring containing one hetero atom selected from N; and n is 0. 2. A pharmaceutical composition comprising: at least one compound of claim 1 , or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier or excipient. 3. The compound of claim 1 , wherein R 2 is methyl, ethyl, n-propyl, isopropyl, n-butyl, allyl, cyclopropyl, methylcyclopropyl, cyclopropylmethylene, benzyl or methoxybenzyl. 4. The compound of claim 1 , wherein -L 3 -R 3 is —OCH 2 CH 2 OCH 3 or —OCH 2 CH 2 CH 2 CH 3 . 5. The compound of claim 1 selected from the group consisting of: or pharmaceutically acceptable salts thereof. 6. The compound of claim 1 wherein -L 3 -R 3 is —OCH 2 CH 2 CH 2 CH 3 . 7. The compound of claim 1 wherein R 4 and R 5 , taken together with the nitrogen to which they are both attached form a heterocycle having the structure:

Assignees

Inventors

Classifications

  • for RNA viruses · CPC title

  • Antivirals · CPC title

  • Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • for DNA viruses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9611268B2 cover?
The present application includes a compound of Formula I or II: or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods that include the administration of such compounds with at least one additional active agent.
Who is the assignee on this patent?
Gilead Sciences Inc
What technology area does this patent fall under?
Primary CPC classification C07D473/18. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).